Video | InSphero


Akura Flow Organ-on-a-Chip Technology

Olivier Frey, InSphero Head of Technology and Platforms, explains in this video how we developed a scalable and versatile organ-on-a-chip system for the study of complex diseases, such as metabolic or cardiovascular diseases, that involve a network of organs that interact with each other.

How we applied InSphero technology to create a human liver NASH model

Watch this video and learn how we apply our scalable technology and organ-on-a-chip solutions to engineer powerful and flexible 3D in vitro platforms for drug efficacy and safety testing and the study of metabolic diseases, such as NASH and Diabetes, and cancers.


Microphysiological systems engineered with organ-on-a-chip Technology

The Akura™ Flow MPS discovery system for organ-on-a-chip solutions provides experimental continuity between single- and multi-tissue testing applications, enabling the seamless integration and optimal utilization of standardized 3D models from a single provider. Complete systems include pre-qualified 3D InSight™ Microtissues, media, assays, and a tilting-based flow control. Watch our video.


3D InSight™ Islet Platform Technology

Watch our video and learn how our uniform and functionally robust 3D InSight™ Human Islet models for diabetes drug discovery and pancreatic islet research can increase productivity in your lab.

Armin Wolf in lab

Maine "207" Newsmagazine visits InSphero Inc. in Brunswick, Maine

In this edition of the online news magazine “207”, Maine Newscenter 5 journalist Amanda Hill interviewed InSphero Chief Scientific Officer Professor Armin Wolf and Chief Business Officer Dr. Frank Junker in our bioproduction facility, located in Brunswick, Maine. View the video:

Screenshot of YouTube video

InSphero Technology Featured in Improbable Success Television Series

What do 3D spheroids, electric cars, and custom fitted pants have in common? When the documentary series Improbable Success focused on Switzerland, it featured interviews with biomedical technology pioneers at ETH Zurich and InSphero. Our CEO Jan Lichtenberg talks about what makes our 3D cell culture technology game-changing for drug discovery and safety testing. You'll also learn more about some other cool and innovative Swiss companies. Watch the video: